Lower thigh subcutaneous and higher visceral abdominal adipose tissue content both contribute to insulin resistance. by Amati, F. et al.
  
 
 
 
 
 
Serveur Académique Lausannois SERVAL serval.unil.ch 
Author Manuscript 
Faculty of Biology and Medicine Publication 
This paper has been peer-reviewed but does not include the final publisher 
proof-corrections or journal pagination. 
Published in final edited form as: 
 
In the absence of a copyright statement, users should assume that standard copyright protection applies, unless the article contains 
an explicit statement to the contrary. In case of doubt, contact the journal publisher to verify the copyright status of an article. 
 
Title: Lower thigh subcutaneous and higher visceral abdominal adipose 
tissue content both contribute to insulin resistance. 
Authors: Amati F., Pennant M., Azuma K., Dubé J.J., Toledo F.G., 
Rossi A.P., Kelley D.E., Goodpaster B.H 
Journal: Obesity 
Year: 2012 May 
DOI: 10.1038/oby.2011.401 
 
 1 
Lower thigh subcutaneous and higher visceral abdominal adipose tissue content both 
contribute to insulin resistance  
 
Running head: Regional adipose tissue and insulin resistance 
 
Authors:  
Francesca Amati1,2 
Marjorie Pennant2,3 
Koichiro Azuma2,4 
John J. Dubé2 
Frederico G.S. Toledo2 
Andrea Rossi2,5 
David E. Kelley2,6 
Bret H. Goodpaster2 
 
Affiliations: 
1 Department of Physiology, University of Lausanne, Lausanne, Switzerland 
2 Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, 
Pittsburgh, PA 
3 Division of Endocrinology and Metabolism, Maryland General Hospital, Baltimore, MD 
4 Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, Japan 
5 Division of Geriatrics, Department of Biomedical and Surgical Science, University of Verona, 
Verona, Italy 
6 Merck Research Laboratories, Rahway, NJ 
 
Corresponding author contact information: 
Bret H. Goodpaster 
University of Pittsburgh 
3459 Fifth Avenue, MUH N810 
Pittsburgh, PA 15213 
Email: bgood@pitt.edu 
Phone: 412-692-2848 
Fax: 412-692-2165 
 
Word count:  
Abstract: 233 
Text not including abstract, acknowledgments, references, tables and figures:  1119 
Number of tables and figures: 1 figure  
 
Keywords: insulin resistance, body composition, subcutaneous adipose tissue, visceral adipose 
tissue 
 2 
ABSTRACT 
It is well known that visceral adipose tissue (VAT) is associated with insulin resistance (IR). 
Considerable debate remains concerning the potential positive effect of thigh subcutaneous 
adipose tissue (TSAT). Our objective was to observe whether VAT and TSAT are opposite, 
synergistic or additive for both peripheral and hepatic IR.  
Fifty-two volunteers (21M/31F) between 30 and 75 years old were recruited from the general 
population. All subjects were sedentary overweight or obese (mean BMI 33.0±3.4 kg/m2). 
Insulin sensitivity was determined by a 4-hr hyperinsulinemic euglycemic clamp with stable 
isotope tracer dilution. Total body fat and lean body mass (LBM) was determined by dual x-ray 
absorptiometry.  Abdominal and mid-thigh adiposity was determined by computed tomography.  
VAT was negatively associated with peripheral insulin sensitivity, while TSAT, in contrast, was 
positively associated with peripheral insulin sensitivity. Subjects with a combination of low VAT 
and high TSAT had the highest insulin sensitivity, subjects with a combination of high VAT and 
low TSAT were the most insulin resistant. These associations remained significant after 
adjusting for age and gender.   
These data confirm that visceral excess abdominal adiposity is associated with insulin resistance 
across a range of middle-age to older men and women, and further suggest that higher thigh 
subcutaneous fat is favorably associated with better insulin sensitivity. This strongly suggests 
that these two distinct fat distribution phenotypes should both be considered in insulin resistance 
as important determinants of cardiometabolic risk. 
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INTRODUCTION 
Visceral adipose tissue (VAT) (1) and intermuscular adipose tissue (IMAT) have been 
shown to be associated with insulin resistance in middle age adults (2).  More recently, lower 
body subcutaneous adipose tissue (3), particularly thigh subcutaneous fat (4), has been identified 
as a potential metabolically protective fat depot. We reported that higher VAT was associated 
with a higher prevalence of metabolic syndrome in older normal weight subjects, but that higher 
thigh subcutaneous adipose tissue (TSAT) was associated with lower prevalence of metabolic 
syndrome in overweight and obese older women (5).  Van Pelt et al. confirmed the favorable 
association of leg fat mass with metabolic risk outcomes in both older men and women (6; 7). 
Recent publications (8; 9) point to the potential positive associations between subcutaneous thigh 
fat tissue and both markers of insulin resistance and the metabolic syndrome, but  it is unclear 
whether subcutaneous thigh fat is positively associated with both peripheral and hepatic insulin 
sensitivity measured directly. Thus, the main objective of this study was to examine whether 
VAT and TSAT have opposite, synergistic or additive associations with both peripheral and 
hepatic insulin resistance. 
 
METHODS AND PROCEDURES 
Subjects 
Volunteers from the general population were included if they were between 30 and 75 
years old, overweight or obese (BMI 25 to 40 m/kg2), weight stable  (<6 lbs weight change in the 
past 6 months), sedentary (self-report of <2 days per week of regular physical activity), non 
smoker, and had a resting systolic blood pressure (SBP) <150mmHg and diastolic blood pressure 
(DBP) <95 mmHg. They were excluded if they had a history of diabetes or taking any 
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medication known to affect glucose homeostasis. The protocol was approved by the University 
of Pittsburgh Institutional Review Board, and all volunteers gave written informed consent.  
Body composition 
Body weight was measured on a calibrated medical digital scale (BWB-800, Tanita 
Corporation, Tokyo, Japan) in undergarments. Height was measured at the same time with a 
wall-mounted stadiometer. A whole body dual energy X-ray absorptiometry (DXA) scan was 
performed to measure whole body fat mass (FM) and lean body mass (LBM) (Lunar Prodigy and 
encore 2005 software version 9.30; GE Healthcare, Milwaukee, MI). Computed tomography 
(9800 CT scanner, General Electrics, Milwaukee, WI) was used to measure cross-sectional area 
total abdominal fat, abdominal subcutaneous (Abdominal SAT), visceral adipose tissue (VAT), 
right mid-thigh subcutaneous adipose tissue (TSAT), intermuscular fat (IMAT), muscle as well 
as muscle attenuation as a marker of muscle lipid content as described elsewhere (10; 11). 
Insulin sensitivity 
A hyperinsulinemic euglycemic glucose clamp was performed to determine rates of 
insulin-stimulated glucose disposal (Rd). This was coupled with stable isotope tracer dilution to 
distinguish and quantify peripheral and hepatic insulin resistance, as well as to quantify basal 
hepatic glucose production (HGP) as described elsewhere (12).  
Statistical analyses 
Pearson product-moment correlations were used to determine the relationship between 
adiposity and insulin resistance. A one-way ANOVA with Tukey HSD adjustment was used to 
compare Rd between different fat distribution phenotypes. All analyses were performed using 
JMP version 5.0.1.2. for Macintosh (SAS, Cary, NC) with an alpha level of 0.05.  
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RESULTS  
Subjects’ characteristics 
Fifty-two subjects (31 women and 21 men) were included in this study. Mean age was 
57.1 ± 12.5 years (range 31 to 74), mean weight 92.4 ± 11.8 kg (range 65.5 to 116.7) and mean 
BMI 33 ± 3.35 kg/m2 (range 26.9 to 39.7).  
Associations between regional fat distribution and insulin resistance   
Body weight was negatively correlated with Rd (r=-0.41, P=0.003). Of the various 
regional fat deposition parameters, only VAT and TSAT were significantly correlated with Rd 
(r=-0.37, P=0.007 and r=0.39, P=0.005 respectively). These associations, however, were in 
opposite directions; higher VAT was associated with lower insulin sensitivity, while higher 
TSAT was associated with higher insulin sensitivity. This remained true when adjusting for total 
body fat. Neither abdominal subcutaneous adipose tissue nor thigh intermuscular adipose tissue 
were significantly correlated with Rd. We did not observe significant correlations between 
regional fat depots and hepatic insulin resistance (the degree of hepatic glucose suppression by 
insulin). These associations remained significant after adjusting for age and gender. 
Based on VAT and TSAT having opposing associations with insulin sensitivity, we 
compared Rd in four distinct phenotypes defined according to whether VAT or TSAT were 
higher or lower than the median value for the entire study sample (Figure 1): high VAT and low 
TSAT (n=13), high VAT and high TSAT (n=10), low VAT and low TSAT (n=12), low VAT and 
high TSAT (n=16). The overall ANOVA (F=3.83, P<0.05) was explained by a significant 
difference between the low VAT and high TSAT group compared to the high VAT and low 
TSAT group.  
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DISCUSSION 
The particularly novel finding of the current study was that greater thigh subcutaneous 
adipose tissue was positively associated with insulin sensitivity across middle age to older 
overweight to obese subjects. Thus visceral adipose tissue and thigh subcutaneous tissue had 
markedly opposite associations with insulin sensitivity. This is the first report to our knowledge 
of this favorable association between thigh subcutaneous adipose tissue content and direct 
assessments of peripheral insulin sensitivity. This finding is in accord with other studies 
demonstrating that thigh subcutaneous adipose tissue content is associated with lower prevalence 
of the metabolic syndrome (5), lower fasting insulin as a marker of higher insulin sensitivity 
(13), better blood glycemic and lipid profiles (4; 9) and inflammation (8).  
Subjects with lower visceral adipose tissue and higher thigh subcutaneous adipose tissue 
had the highest degree of insulin sensitivity. In contrast, those with higher visceral fat and lower 
thigh subcutaneous adipose tissue had the most severe insulin resistance.  Thus this data strongly 
suggest that these fat depots should be considered together and not in isolation. This study was 
not powered to specifically examine gender differences, thus we were not able to demonstrate 
associations between regional fat depots separately within men and women. Nevertheless, 
multivariate regression analysis indicated that these associations between the adipose tissue 
distribution phenotypes and insulin sensitivity remained significant adjusting for gender. 
Moreover, some men had high insulin sensitivity, high thigh subcutaneous fat and low visceral 
fat, whereas some women were insulin resistant with low thigh subcutaneous fat and high 
visceral fat. These data strongly suggest that these fat distribution phenotypes can be present in 
both men and women. 
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  In summary, subcutaneous thigh adipose tissue appears to exert a protective influence 
against peripheral insulin resistance in obesity regardless of age and gender, which is 
independent of the opposite and negative association observed between visceral abdominal fat 
and insulin sensitivity. Further investigations are needed to examine the mechanisms underlying 
individual variation in fat distribution, how these mechanisms are affected by aging, and how 
this may be implicated in the prevention and treatment of insulin resistance and cardiometabolic 
risk.  
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FIGURE LEGENDS 
 
Figure 1 Insulin sensitivity (Rd) distribution by phenotype group 
Box plots and means (black square). VAT: visceral adipose tissue, TSAT: thigh subcutaneous 
adipose tissue. 
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